Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Link Biosystems Inc
Profile last edited on: 7/26/24      CAGE: 96RQ8      UEI: XML9QKHWRPR3

Business Identifier: Ssystemic human pre-clinical model designed for cancer drug development
Year Founded
2021
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

15 Sycamore Lane
Irvington, NY 10533
   (813) 766-7280
   N/A
   www.linkbiosystems.com
Location: Single
Congr. District: 16
County: Westchester

Public Profile

Though other supporting documentation appears limited, firm is decsribed as developing a systemic human pre-clinical model designed for cancer drug development. Further it is noted 0 but nor confirmed - tha the company offers micro-physiological systems, enabling patients to receive optimal treatment.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$878,790
Phase II Dollars
$0
Total Awarded
$878,790

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 1 NIH $327,767
Project Title: Cell Expansion Bioreactors for Assay-Ready Immunocompetent Patient Models
2023 1 NIH $275,396
Project Title: Efficient Differentiation, Scale-Up, and Maturation of iPS Derived Cardiomyocytes
0 1 NIH $275,627
Project Title: Efficient Scale-Up of IPS Cells for Autologous Cell Therapy Workflow

Key People / Management

  Kacey Ronaldson -- President

Company News

There are no news available.